Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice.
The postsynaptic muscle-specific kinase (MuSK) coordinates formation of the neuromuscular junction (NMJ) during embryonic development. Here we have studied the effects of MuSK autoantibodies upon the NMJ in adult mice. Daily injections of IgG from four MuSK autoantibody-positive myasthenia gravis patients (MuSK IgG; 45 mg day(1)i.p. for 14 days) caused reductions in postsynaptic ACh receptor (AChR) packing as assessed by fluorescence resonance energy transfer (FRET). IgG from the patients with the highest titres of MuSK autoantibodies caused large (51-73%) reductions in postsynaptic MuSK staining (cf. control mice; P < 0.01) and muscle weakness. Among mice injected for 14 days with control and MuSK patient IgGs, the residual level of MuSK correlated with the degree of impairment of postsynaptic AChR packing. However, the loss of postsynaptic MuSK preceded this impairment of postsynaptic AChR. When added to cultured C2 muscle cells the MuSK autoantibodies caused tyrosine phosphorylation of MuSK and the AChR beta-subunit, and internalization of MuSK from the plasma membrane. The results suggest a pathogenic mechanism in which MuSK autoantibodies rapidly deplete MuSK from the postsynaptic membrane leading to progressive dispersal of postsynaptic AChRs. Moreover, maintenance of postsynaptic AChR packing at the adult NMJ would appear to depend upon physical engagement of MuSK with the AChR scaffold, notwithstanding activation of the MuSK-rapsyn system of AChR clustering.
Cole
R N
RN
Physiology, Anderson Stuart Bldg (F13), University of Sydney, NSW 2006 Australia.
Ghazanfari
N
N
Ngo
S T
ST
Gervásio
O L
OL
Reddel
S W
SW
Phillips
W D
WD
D000818:Animals; D001323:Autoantibodies / Q000502:physiology* / Q000633:toxicity; D002478:Cells, Cultured; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000502:physiology / Q000633:toxicity; D045170:Matrix Attachment Regions / Q000502:physiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D009157:Myasthenia Gravis / Q000201:enzymology / Q000209:etiology / Q000378:metabolism*; D009469:Neuromuscular Junction / Q000201:enzymology / Q000235:genetics / Q000378:metabolism*; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000172:deficiency* / Q000276:immunology / Q000378:metabolism; D011950:Receptors, Cholinergic / Q000737:chemistry / Q000172:deficiency / Q000276:immunology / Q000378:metabolism*; D013569:Synapses / Q000201:enzymology* / Q000235:genetics / Q000378:metabolism
D001323:Autoantibodies; D007074:Immunoglobulin G; D011950:Receptors, Cholinergic; C095714:MUSK protein, human; C511695:MuSK protein, mouse; D020794:Receptor Protein-Tyrosine Kinases